Like the patent expiration of erectile dysfunction, will expired ‘Avodart’ lead changes?
Since the substance patent of GSK’s ‘Avodart(dutasteride),’ used as a hair loss and prostatism treatment, was expired today(21st), domestic pharmaceutical companies, such as Kukje Pharm, KyungDong Pharm, Kwang Dong Pharmaceutical, Daewoong Pharmaceutical and Dongkoo Bio&Pharma, are preparing for ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
